KBC Group
ANGO icon

KBC Group’s AngioDynamics ANGO Stock Holding History

KBC Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,673
Closed -$20K – 1862
2023
Q3 		$20K Sell
2,673
-760
-22% -$6.32K ﹤0.01% 1879
2023
Q2 		$36K Hold
3,433
– – ﹤0.01% 1421
2023
Q1 		$35K Hold
3,433
– – ﹤0.01% 1448
2022
Q4 		$47K Hold
3,433
– – ﹤0.01% 1402
2022
Q3 		$70K Hold
3,433
– – ﹤0.01% 1303
2022
Q2 		$66K Buy
+3,433
New +$70.3K ﹤0.01% 1357
2020
Q1 		– Sell
-5,902
Closed -$94K – 1288
2019
Q4 		$94K Sell
5,902
-32,239
-85% -$492K ﹤0.01% 1364
2019
Q3 		$703K Hold
38,141
– – 0.01% 991
2019
Q2 		$751K Sell
38,141
-16,962
-31% -$345K 0.01% 942
2019
Q1 		$1.26M Sell
55,103
-2,267
-4% -$49.2K 0.01% 777
2018
Q4 		$1.16M Sell
57,370
-17,334
-23% -$359K 0.01% 701
2018
Q3 		$1.62M Buy
74,704
+8,365
+13% +$186K 0.01% 760
2018
Q2 		$1.48M Hold
66,339
– – 0.01% 683
2018
Q1 		$1.14M Buy
66,339
+10,140
+18% +$169K 0.01% 739
2017
Q4 		$935K Hold
56,199
– – 0.01% 825
2017
Q3 		$960K Sell
56,199
-10,273
-15% -$173K 0.01% 817
2017
Q2 		$1.08M Buy
66,472
+925
+1% +$14.6K 0.01% 746
2017
Q1 		$1.14M Buy
65,547
+21,871
+50% +$366K 0.01% 824
2016
Q4 		$737K Buy
43,676
+15,108
+53% +$252K 0.01% 931
2016
Q3 		$501K Hold
28,568
– – 0.01% 960
2016
Q2 		$411K Buy
28,568
+3,766
+15% +$47.1K 0.01% 933
2016
Q1 		$305K Buy
24,802
+11,239
+83% +$124K 0.01% 956
2015
Q4 		$165K Hold
13,563
– – ﹤0.01% 1028
2015
Q3 		$179K Sell
13,563
-4,768
-26% -$72K ﹤0.01% 1031
2015
Q2 		$301K Sell
18,331
-5,634
-24% -$93.5K ﹤0.01% 1030
2015
Q1 		$426K Buy
23,965
+11,594
+94% +$215K 0.01% 943
2014
Q4 		$235K Buy
+12,371
New +$210K ﹤0.01% 1153

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

KBC Group's ANGO Position: Q4 2023 in Review

KBC Group sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 2,673 shares — an estimated $20K sold.

KBC Group first reported a position in ANGO in Q4 2014 and held it in 27 quarters. The position peaked at $1.62M in Q3 2018. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

  • KBC Group reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
  • KBC Group sold 2,673 AngioDynamics shares in Q4 2023, an estimated $20K.
  • KBC Group first reported a position in AngioDynamics in Q4 2014 and held it in 27 quarters.
  • KBC Group's AngioDynamics position peaked at $1.62M in Q3 2018.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.